Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

Clinical trial NCT00871338 · COMPLETED

Trial details

NCT number: NCT00871338
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neisseria Meningitidis Haemophilus Influenzae Type b

Start date: 2009-06-24
Primary completion: 2010-03-31
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.